Small caps in general have had a bad run over the past 12 months. It's been tough picking a winner. PM stocks in particular have been smashed.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
